HIV/AIDS Therapy
Buprenorphine therapy in primary HIV care setting improves therapeutic adherence
Published in AIDS Weekly, April 17th, 2006
Investigators in the United States report, "Opiate dependence among human immunodeficiency virus (HIV)-infected patients has been associated with negative clinical outcomes, yet few affected patients receive appropriate and coordinated treatment for both conditions. The introduction of buprenorphine maintenance therapy into HIV care settings provides an opportunity for providers to integrate treatment for opiate dependence into their practices."
S. Basu and colleagues at Yale University wrote, "Buprenorphine maintenance therapy has been associated with...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2006-04-17)
More Articles from AIDS Weekly
- HIV/AIDS Drug Development
HIV-1 replication inhibited with small soluble Tat peptides - HIV/AIDS Pathogenesis
HIV-1 gag destabilizes gp120 and gp4l interaction - HIV/AIDS Pathogenesis
HIV-1 tropism switch from CCR5-to-CXR4 driven by naive and memory cell turnover - HIV/AIDS Vertical Transmission
CCR5 gene polymorphisms related to vertical HIV transmission risk - Hepatitis C & HIV Coinfection
Hepatitis C virus coinfection is associated with decreased adherence to antiretroviral therapy - Atherosclerosis
Atherosclerosis development is associated with antiretroviral HIV therapy - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
